Development of an orthotopic murine model of a patient- derived pancreatic adenocarcinoma to evaluate the tissue specificity of two novel fluorescent compounds.

AACR Poster | New translational model 

Development of an orthotopic murine model of a patient- derived pancreatic adenocarcinoma to evaluate the tissue specificity of two novel fluorescent compounds 

2020 E-AACR Abstract

Peggy Provent1, Elodie Marie-Dit-Chatel1, Jordan Longin1, Stanislas Urbain2, François Scherninski2 and Cyril Berthet1.
1- Oncodesign | Dijon
2- Proimaging | Paris

Fluorescent dyes have been used in medical diagnostics for over 50 years. The emergence of new fluorescent imaging technology in support of surgery and the need for increased sensitivity and precision have driven the search for novel fluorescent molecules. Orthotopic patient-derived pancreatic tumor models provide a closely related human tumor within organ-specific tumor microenvironment, which was well suited to the evaluation of the tissue specificity of two novel fluorescent compounds.

To this end, we have developed an orthotopic tumor model of IM-PAN-15 (PDX model developed within the IMODI consortium), a patient derived pancreatic adenocarcinoma, in mice. Tumor cells were amplified subcutaneously in SCID mice and the resulting fragments subsequently surgically implanted into the pancreas of irradiated BALB/c nude mice. Tumor development was monitored in vivo by MRI at three time points. Fluorescent compounds were injected intravenously 36 days after tumor fragment implantation, when mean tumor volumes were approximately 70 mm³.

Ex-vivo fluorescent imaging showed that 2h after injection, the two novel fluorescent compounds were present in the pancreas and tumor at roughly equivalent amounts. However, 48h after injection, a clear preferential distribution for the tumor was observed, with both compounds producing an approximately four-fold higher fluorescent signal in the tumor than in the surround pancreatic tissue. This effect persisted six days after injection, although the signal decreased over time. In comparison, indocyanine green, a dye widely used in medical diagnostics, showed no specific accumulation in either the pancreas or tumor.

Fluorescent imaging mouse wo name 600 562

In conclusion, we report the development of a clinically relevant, patient-derived orthotopic tumor model and demonstrate its use in the investigation of tissue specificity of two novel fluorescent compounds.

Please find below our 2020 e-AACR. To obtain it, please request it!

Novel fluorescent probe evaluated in an orthotopic pancreatic PDX model

Imaging Poster AACR 2020

Invalid Input

Invalid Input

Invalid Input

your address is not a proper one. Please check.

Invalid Input

We care about your privacy.
Since you are a valuable customer or prospect, we want to make sure that you can choose to stay connected with Oncodesign. Oncodesign collectgs your data to provide you with information regarding our offering and news.
In accordance with the law "Informatique et Libertés", you can exercise your right of access to the data concerning you and have them rectified by contacting odsmarketing@oncodesign.com.
Your Email address has not been and will not be given to third parties. 

Oncodesign is registered with CNIL under number 2102182.

I want to discuss your poster with your expert

Our expert teams are available to discuss your projects to find the best of our options to assess your compound. Challenge us!